Oliceridine as a Novel Selective mu-receptor G-protein Pathway Modulator: A Narrative review [PDF]
Objective: To review the literature on equianalgesic efficacy and better safety(less respiratory depression and gastrointestinal dysfunction) of oliceridine versus opioid analgesic in moderate to severe postoperative pain.
Uma Advani +5 more
doaj +3 more sources
Background: In the absence of head-to-head comparative data from randomized controlled trials, indirect treatment comparisons (ITCs) may be used to compare the relative effects of treatments versus a common comparator (either placebo or active ...
Gary Oderda +2 more
exaly +3 more sources
Determination of the effective dose of oliceridine combined with propofol using the modified Dixon’s up-and-down method in painless gastroscopy [PDF]
ObjectiveTo investigate the median effective dose (ED50) and 95% effective dose (ED95) of oliceridine combined with propofol for painless gastroscopy in adults.MethodsPatients underwent painless gastroscopy were divided to male and female cohorts.
Jinfeng Cao +4 more
doaj +4 more sources
Low Incidence of Postoperative Respiratory Depression with Oliceridine Compared to Morphine: A Retrospective Chart Analysis [PDF]
Background. Oliceridine, an investigational IV opioid, is a first-in-class G-protein selective agonist at the μ-opioid receptor. The G-protein selectivity results in potent analgesia with less recruitment of β-arrestin, a signaling pathway associated ...
Sergio Bergese +9 more
doaj +4 more sources
Overview and Prospects of the Clinical Application of Oliceridine [PDF]
Kun Yi,* Wenjie Sun,* Wen Yu, Shibiao Chen Department of Anesthesiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, People’s Republic of China*These authors contributed
Yi K, Sun W, Yu W, Chen S
doaj +4 more sources
Estimation of median effective doses and 95% effective doses of oliceridine combined with propofol for day-case hysteroscopy under total intravenous anesthesia with preserved spontaneous breathing: an up-and-down sequential allocation trial [PDF]
Background Oliceridine is a novel developed G protein-biased µ-opioid receptor agonist, offering a significant reduction in the risk of opioid-related respiratory depression and a lower incidence of gastrointestinal adverse effects.
Jiliang He +7 more
doaj +3 more sources
The median effective dose of esketamine with different doses of oliceridine during hysteroscopic surgery [PDF]
PurposeThis study aimed to investigate the impact of different doses of oliceridine on the ED50 of esketamine during hysteroscopic surgery. The objective was to establish an optimal dosing regimen that facilitates the development of an effective and safe
Min Shi +6 more
doaj +4 more sources
A Bibliometric and Visual Analysis of Oliceridine Research (2013–2024)
Cheng Song,1,* Xinxing Huang,2,* Nianping Chen,1 Qiliang Song,3 Yuanli Qiu1 1Department of Anesthesiology, Affiliated Hospital of Shaoxing University, Zhejiang, 312000, People’s Republic of China; 2Department of Anesthesiology, Jinhua Maternal ...
Song C, Huang X, Chen N, Song Q, Qiu Y
doaj +2 more sources
Background Oliceridine is a G protein–biased µ-opioid, a drug class that is associated with less respiratory depression than nonbiased opioids, such as morphine. The authors quantified the respiratory effects of oliceridine and morphine in elderly volunteers.
Simons, P. +13 more
openaire +5 more sources
Journey of Oliceridine: A Novel Opioid
Opioid analgesics play a crucial role in the management of acute pain, but its use is often limited by various adverse effects, especially nausea, vomiting, and respiratory depression.
A Tejus +3 more
doaj +2 more sources

